<?xml version="1.0" encoding="UTF-8"?>
<p id="p0340">Among potential anti-COVID-19 drugs we report the phytochemical geniposide; this TMPRSS2 inhibitor should be validated for treatment of coronavirus infection as it does not show toxicity in humans, since it has been reported that geniposide cannot cross the bloodâ€“brain barrier and it is not absorbed by the gastrointestinal tract 
 <xref rid="b0450" ref-type="bibr">[90]</xref>. In addition, geniposide protects against sepsis-induced myocardial dysfunction by activating AMPK which suppresses myocardial reactive oxygen species (ROS) accumulation 
 <xref rid="b0520" ref-type="bibr">[104]</xref>.
</p>
